0000899243-21-006355.txt : 20210212 0000899243-21-006355.hdr.sgml : 20210212 20210212174351 ACCESSION NUMBER: 0000899243-21-006355 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210210 FILED AS OF DATE: 20210212 DATE AS OF CHANGE: 20210212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sandercock Colin CENTRAL INDEX KEY: 0001724870 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 21630195 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-10 0 0001645460 Cue Biopharma, Inc. CUE 0001724870 Sandercock Colin C/O CUE BIOPHARMA, INC. 21 ERIE STREET CAMBRIDGE MA 02139 0 1 0 0 SVP, General Counsel and Sec Stock Option (right to buy) 15.55 2021-02-10 4 A 0 50000 0.00 A 2031-02-09 Common Stock 50000 50000 D This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 10, 2021. /s/ Colin Sandercock 2021-02-12